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Infectious diseases occur very frequently in children and adults. Novel diagnostic methods have
permitted us to expand our knowledge on their epidemiology and pathophysiology [1]. Emerging
pathogens have appeared in recent years, raising alerts among health authorities. Moreover, new
anti-infective treatments have been discovered, and it is extremely important to know when to use
them to avoid abuse and misuse of these new drugs because of possible negative antimicrobial
resistance outcomes [2]. Furthermore, new vaccines have appeared on the market, and it is essential
that practitioners be informed of their impact on public health [3]. For these reasons, the International
Journal of Molecular Sciences has decided to dedicate a Special Issue to the pathophysiology, diagnostics
and prevention of infectious diseases [4]. A total of 22 papers consisting of 12 original research
studies, 9 reviews and 1 case report have been published in the Special Issue, as detailed in Table 1.
This Special Issue has the main goal of presenting recent advances in different aspects of infectious
diseases, covering pediatric and adult issues as well as different pathogens.
Table 1. Summary of papers in the Special Issue “Infectious diseases: pathophysiology, diagnostics
and prevention”, arranged by topic.
Authors Title Topics Type
Pugni et al. [5]
Exchange transfusion in the treatment of
neonatal septic shock: A ten-year experience in a
neonatal intensive care unit
Bacteria Original research
Castellazzi et al. [6] Update on the management of pediatric acuteosteomyelitis and septic arthritis Bacteria Review
Krone et al. [7] Dried saliva spots: A robust method for detectingStreptococcus pneumoniae carriage by PCR Bacteria Original research
Ieni et al. [8]
Morphological and cellular features of innate
immune reaction in Helicobacter pylori gastritis:
A brief review
Bacteria Original research
Liu et al. [9]
Immunogenicity and cross-protective efficacy
induced by outer membrane proteins from
Salmonella typhimurium mutants with truncated
LPS in mice
Bacteria Original research
Gallo et al. [10]
Campylobacter jejuni fatal sepsis in a patient with
Non-Hodgkin’s lymphoma: Case report and
literature review of a difficult diagnosis
Bacteria Case report
Korb et al. [11] Mycobacterium tuberculosis: Manipulator ofprotective immunity Bacteria Review
Galli et al. [12]
Pediatric tuberculosis in Italian children:
Epidemiological and clinical data from the Italian
Register of Pediatric Tuberculosis
Bacteria Original research
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Table 1. Cont.
Authors Title Topics Type
Sotgiu et al. [13] Carbapenems to treat multidrug and extensivelydrug-resistant tuberculosis: A systematic review Bacteria Review
Tramuto et al. [14]
The molecular epidemiology and evolutionary
dynamics of influenza B virus in two Italian
Regions during 2010–2015: The experience of
Sicily and Liguria
Viruses Original research
Esposito et al. [15]
Identification of human Adenovirus in
respiratory samples with Luminex Respiratory
Virus Panel Fast V2 assay and real-time
polymerase chain reaction
Viruses Original research
Gagliardi et al. [16] The impact of specific viruses on clinical outcomein children presenting with acute heart failure Viruses Original research
Bozzola et al. [17] Varicella skin complications in childhood: A caseseries and a systematic review of the literature Viruses Original research
Vorsters et al. [18] Long-term follow-up of HPV infection usingurine and cervical quantitative HPV DNA testing Viruses Original research
Focà et al. [19]
Screening for neurocognitive impairment in
HIV-infected individuals at first contact after HIV
diagnosis: The experience of a large Clinical
Center in Northern Italy
Viruses Original research
Latronico et al. [20]
Liver fibrosis in HCV monoinfected and
HIV/HCV coinfected patients: Dysregulation of
matrix metalloproteinases (MMPs) and their
tissue inhibitors TIMPs and effect of HCV
protease inhibitor
Viruses Original research
Rigante et al. [21]
Critical overview of the risk scoring systems to
predict non-responsiveness to intravenous
immunoglobulin in Kawasaki syndrome
Emerging
infectious-related
diseases
Review
Torreggiani et al. [22] Recurrent fever in children
Emerging
infectious-related
diseases
Review
Principi &
Esposito [23]
Infectious discitis and spondylodiscitis
in children
Emerging
infectious-related
diseases
Review
Di Pasquale et al. [24] Non-intensive care unit acquired pneumonia:A new clinical entity?
Emerging
infectious-related
diseases
Review
De Martino [25] Dismantling the taboo against vaccines inpregnancy Vaccines Review
Orsi et al. [26]
Pneumococcus and the elderly in Italy: A
summary of available evidence regarding
carriage, clinical burden of lower respiratory
tract infections and on-field effectiveness of
PCV13 vaccination
Vaccines Review
Nine manuscripts (five original research studies, three reviews and one case report) discussed
bacterial infections, showing the significant impact of these infections in terms of disease burden
among all age groups as well as advances in diagnostic and therapeutic approaches.
In a 10-year retrospective study, Pugni et al. showed the burden of neonatal septic shock in a
neonatal intensive care unit and demonstrated advantages in management with a reduction in the
mortality rate through the use of exchange transfusion in addition to standard therapy [5]. According
to the authors’ conclusions, the lack of adverse events should encourage the use of this procedure in
the treatment of neonates with septic shock.
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Castellazzi et al. provided clinicians with an update on recent controversies and advances
regarding the management of acute osteomyelitis and septic arthritis in children [6]. In recent
years, the emergence of bacterial species resistant to commonly used antibiotics that are particularly
aggressive highlights the need for further research to optimize treatment approaches and to develop
new molecules able to fight the war against acute osteoarticular infection in pediatric patients.
Krone et al. tested the feasibility of using dried saliva spots (DSS) for studies on pneumococcal
carrier states [7]. Saliva samples from children and pneumococcus-spiked saliva samples from healthy
adults were applied to paper, dried and stored, with and without desiccant, at temperatures ranging
from−20 to 37 ◦C for up to 35 days. DNA extracted from DSS was tested with quantitative-polymerase
chain reaction (PCR) specifically for Streptococcus pneumoniae. The authors showed that there were
no differences in the results when spiking saliva with varied pneumococcal strains. The collection of
saliva can be particularly useful in surveillance studies conducted in remote settings, as it does not
require trained personnel and DSS can withstand various transportation conditions.
Ieni et al. discussed the role of cellular morphological effectors of innate immunity during
Helicobacter pylori infection and gastric carcinogenesis [8], whereas Liu et al. analyzed the different
immunogenicity of outer membrane proteins from Salmonella mutants [9] and Gallo et al. reported a
case of fatal sepsis caused by Campylobacter jejuni in a 76-year-old Caucasian man with non-Hodgkin’s
lymphoma [10].
Interestingly, three of the manuscripts on bacterial infections analyzed topics related to different
aspects of tuberculosis, highlighting that Mycobacterium tuberculosis remains a global health challenge.
Korbe et al. presented evidence of the mechanisms by which M. tuberculosis manipulates the protective
immune response to become a pathological productive infection [11].
Galli et al. presented results from a multicenter study conducted in 27 pediatric hospitals, pediatric
wards and public health centers in Italy using a standardized form covering the period of time between
1 January 2010 and 31 December 2012 [12]. The results showed that improving the surveillance of
childhood tuberculosis is important for public health care workers and pediatricians. Moreover, it was
demonstrated that a non-negligible proportion of children had drug-resistant tuberculosis and were
treated with second-line drugs, most of which are off-label for the pediatric age range.
Finally, Sotgiu et al. performed a systematic review to evaluate the efficacy, safety and tolerability
of carbapenems in treatment of multi-drug-resistant tuberculosis [13]. Two studies on ertapenem,
one on imipenem and four on meropenem, all published between 2005 and 2016, were identified.
The treatment success was greater than 57% in five studies with culture conversion rates between 60%
and 94.8%. The safety and tolerability of carbapenems appeared to be very good, with the proportion
of adverse events attributable to carbapenems below 15%.
Seven manuscripts (all original research) discussed viral infections, showing how molecular
diagnostics have permitted us to expand our knowledge on viral epidemiology and pathogenesis.
Tramuto et al. reconstructed the phylogenetic relationships and genetic diversity of the
hemagglutinin gene sequences of 197 influenza B strains circulating in both southern (Sicily) and
northern (Liguria) Italy between 2010 and 2015 [14]. Phylogenetic analysis showed clusters in the
B/Victoria clade 1A/1B (n = 29, 14.7%) and the B/Yamagata clades 2 (n = 112, 56.8%) and 3 (n = 56,
28.4%). Both influenza B lineages were found to co-circulate during the study period, providing
evidence to support the adoption of quadrivalent influenza vaccines.
Esposito et al. compared the last version of the Respiratory Virus Panel (RVP) Fast assay for
human adenovirus (hAdv) detection with specific real-time PCR, showing that the RVP Fast V2 assay
has important limitations for the detection of hAdv and cannot be used either to evaluate whether
hAdvs are the main etiologic agent responsible for an outbreak or when epidemiological studies are
performed [15].
Gagliardi et al. evaluated the prevalence, type and clinical impact of specific viral genomes
in endomyocardial biopsies (EMBs) collected between 2001 and 2013 from 63 children admitted for
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acute heart failure (median age 2.8 years) [16]. Presence of a virus-positive EMB was associated with
improvement in cardiac function over time and better long-term prognosis.
Bozzola et al. described varicella skin complications in hospitalized immunologically healthy
children over a nine-year period, showing that they occurred in 2.6%–41.2% of cases [17].
Vorsters et al. investigated the use of urine samples, which can be collected at home, instead of
cervical samples, for follow-up of a human papillomavirus (HPV) intervention trial, demonstrating
that urine sampling may be a valid alternative to cervical samples [18].
Latronico et al. showed that the decrease of matrix metalloproteinases (MMP-9) following
hepatitis C (HCV) protease inhibitor treatment suggests a positive effect on the reduction of liver
inflammation [19].
Focà et al. assessed neurocognitive profiles of newly detected HIV-infected patients, showing
that complete neuropsychological screening must be recommended for all patients at the time of
HIV-infection diagnosis [20].
Four manuscripts (all reviews) discussed emerging infectious-related diseases, highlighting the
potential role of different pathogens in immune-mediated disorders.
Rigante et al. showed that early and definite determination of likely intravenous immunoglobulin
non-responders who require additional therapies to reduce the development of coronary artery
involvement in children with Kawasaki syndrome is still a challenge [21].
Torreggiani et al. summarized infectious and non-infectious causes of recurrent fever in pediatric
patients [22], whereas Principi and Esposito discussed recent concepts regarding pediatric discitis and
spondylodiscitis [23] and Di Pasquale et al. reviewed non-intensive care unit–acquired pneumonia [24].
Two manuscripts (both reviews) discussed vaccines, focusing on targets that, in recent years,
have been considered as priorities for vaccine use.
De Martino discussed the importance of maternal immunization, highlighting that strong
communication strategies are effective for reducing parental vaccine hesitancy and approvals by
regulatory agencies for the use of vaccines during pregnancy are needed [25].
Finally, Orsi et al. summarized the available evidence from Italy and Liguria regarding
pneumococcal carriage, the burden of community-acquired pneumonia and lower respiratory tract
infections and the on-field effectiveness of 13-valent pneumococcal conjugate immunization in adults
and the elderly [26].
Overall, the 22 contributions published in the Special Issue illustrate the advances in the field of
infectious diseases in recent years due to new diagnostic possibilities, the involvement of bacteria and
viruses in acute diseases and in different medical disciplines and the importance of prevention with
effective and safe vaccines. We would like to thank all the authors who contributed to the Special Issue,
and we remain hopeful that adequate knowledge of how to diagnose, treat and prevent infectious
diseases will help to contain global morbidity and mortality.
Conflicts of Interest: The author declares no conflict of interest.
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